市場調査レポート

商品コード

1563405

植込み型医療機器の市場規模、シェア、成長分析、製品別、生体材料別、最終用途別、地域別 - 産業予測、2024年～2031年

Implantable Medical Devices Market Size, Share, Growth Analysis, By Product (Cardiovascular Implants, Orthopedic Implants), By Biomaterial (Ceramic, Metallic), By End Use (Hospitals, Outpatient Facilities), By Region - Industry Forecast 2024-2031

出版日: 2024年09月29日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の植込み型医療機器の市場規模は、2022年に905億米ドルとなり、2023年の961億1,000万米ドルから、2031年までには1,555億1,000万米ドルに成長し、予測期間（2024年～2031年）のCAGRは6.20%で成長する見通しです。

植込み型医療機器は、体内または体表面に設置され、さまざまな機能を果たすように設計されています。これらのデバイスの多くは、欠損した身体の一部を補う人工関節や人工部品として機能します。また、投薬や生物学的プロセスの監視、身体的補助など、サポート的な役割を果たすものもあります。インプラントは、その目的に応じて、診断、モニタリング、治療のために永久にそのまま使用されることもあれば、その機能が不要になった時点で取り外されることもあります。長期的なインプラントは、複雑な負荷条件やデバイスの長寿命化に対する要求の高まりといった課題に直面しながらも、安定した温度環境で作動できるという利点があります。平均寿命が延びるにつれて、加齢に関連した健康状態が顕著に増加し、寿命を延ばすように設計された医療補助器具に対するニーズが高まっています。これには、治療法、インプラント、人工関節、進行中の薬理学的治療における技術革新が含まれます。組織、金属、骨、ポリマー、皮膚、セラミックなど、これらのデバイスの製造に使用される材料の範囲は、医療技術と材料科学の進歩により、近い将来さらに拡大すると予想されます。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主要な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Medtronic（Ireland）
Abbott Laboratories（US）
Johnson & Johnson（US）
Boston Scientific Corporation（US）
Smith & Nephew plc（UK）
Stryker（US）
Cochlear Limited（Australia）
Integra LifeSciences（US）
LivaNova PLC（UK）
Biotronik SE and Co. KG（Germany）
Zimmer Biomet Holdings, Inc.（US）
Edwards Lifesciences Corporation（US）
Hearing Life（US）
Nevro Corp.（US）
Orthofix Medical Inc.（US）
NuVasive, Inc.（US）
W. L. Gore & Associates, Inc.（US）
AngioDynamics, Inc.（US）
Ramsay Sante（France）
Hologic, Inc.（US）
Abiomed, Inc.（US）
Straumann Holding AG（Switzerland）
KARL STORZ SE & Co. KG（Germany）

Product Code: SQMIG35A2510

Global Implantable Medical Devices Market size was valued at USD 90.50 billion in 2022 and is poised to grow from USD 96.11 billion in 2023 to USD 155.51 billion by 2031, growing at a CAGR of 6.20% during the forecast period (2024-2031).

Implantable medical devices are designed to be placed either inside the body or on its surface, serving various functions. Many of these devices act as prostheses or artificial components to replace missing body parts. Other implants play supportive roles, such as administering medication, monitoring biological processes, or providing physical assistance. Depending on their purpose, implants can either remain in place permanently for diagnostic, monitoring, or therapeutic reasons, or be removed once their function is no longer needed. Long-term implants benefit from their ability to operate in a stable temperature environment, although they face challenges like complex loading conditions and increasing demands for device longevity. With rising life expectancy, there has been a notable increase in age-related health conditions, leading to a greater need for medical aids designed to extend life. This includes innovations in therapies, implants, prostheses, and ongoing pharmacological treatments. The range of materials used in creating these devices-including tissues, metals, bones, polymers, skin, and ceramics-is expected to expand further in the near future, driven by advancements in medical technology and materials science.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Implantable Medical Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Implantable Medical Devices Market Segmental Analysis

Global Implantable Medical Devices Market is segmented by Product, Biomaterial, End Use, and region. Based on Product, the market is segmented into Cardiovascular Implants, Orthopedic Implants, Ophthalmology Implants, Dental Implants, Aesthetic Implants, and Neurology Implants. Based on Biomaterial, the market is segmented into Ceramic, Metallic, Polymers, and Natural. Based on End Use, the market is segmented into Hospitals, Outpatient Facilities, and Specialty Clinics & Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Implantable Medical Devices Market

The growth of the implantable medical devices industry is significantly driven by the rising incidence of disorders across various medical fields, including cardiovascular, ophthalmology, orthopedics, plastic surgery, dental care, and neurology. For example, cardiovascular diseases such as coronary artery disease (CAD), congenital heart disease (CHD), and strokes are major contributors to global mortality rates. The World Health Organization (WHO) reports that approximately 17.9 million deaths occur annually due to cardiovascular conditions, accounting for about 31% of global deaths. Within this, around 7.4 million deaths are attributed to CHD, while approximately 6.7 million are due to strokes. Projections indicate that by 2030, cardiovascular diseases will be responsible for an estimated 23.6 million deaths worldwide. The prevalence of these diseases is largely driven by factors such as unhealthy diets, excessive alcohol consumption, tobacco use, and lack of physical activity. This increasing prevalence results in a significant number of deaths and is expected to continue rising in the future. Consequently, this growing trend is anticipated to expand the market for implantable medical devices, as there will be an increasing demand for innovative solutions to manage and treat these conditions effectively.

Restraints in the Global Implantable Medical Devices Market

The market growth for implantable medical devices may be constrained by the high costs associated with implantation procedures and a shortage of trained medical professionals. The significant expense of these procedures can limit accessibility and reduce the adoption rate of new technologies. Additionally, the scarcity of skilled professionals in the field further exacerbates these challenges, as it impacts the availability and quality of surgical interventions.

Market Trends of the Global Implantable Medical Devices Market

A significant trend shaping the global implantable medical devices market is the emergence of connected medical devices. These devices offer enhanced value and efficiency for healthcare providers by facilitating real-time data capture and transmission. Advances in connectivity technologies and supporting systems have given rise to the Internet of Medical Things (IoMT), which integrates various connected devices to improve patient care and operational efficiency. As the adoption of connected medical devices continues to rise, it is expected to open up numerous opportunities in the market in the coming years.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Trade Analysis
Supply chain Analysis
Case study Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Implantable Medical Devices Market by Product

Market Overview
Cardiovascular Implants
Orthopedic Implants
Ophthalmology Implants
Dental Implants
Aesthetic Implants
Neurology Implants

Implantable Medical Devices Market by Biomaterial

Market Overview
Ceramic
Metallic
Polymers
Natural

Implantable Medical Devices Market by End Use

Market Overview
Hospitals
Outpatient Facilities
Specialty Clinics & Centers

Implantable Medical Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cochlear Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE and Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hearing Life (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthofix Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NuVasive, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
W. L. Gore & Associates, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ramsay Sante (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abiomed, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Straumann Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KARL STORZ SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

植込み型医療機器の市場規模、シェア、成長分析、製品別、生体材料別、最終用途別、地域別 - 産業予測、2024年～2031年

Implantable Medical Devices Market Size, Share, Growth Analysis, By Product (Cardiovascular Implants, Orthopedic Implants), By Biomaterial (Ceramic, Metallic), By End Use (Hospitals, Outpatient Facilities), By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主要な市場の考察

植込み型医療機器市場：製品別

植込み型医療機器市場：生体材料別

植込み型医療機器市場：最終用途別

植込み型医療機器市場規模：地域別